title: Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient.
abstract: OBJECTIVE
  To report a case of Chryseobacterium indologenes ventilator-associated pneumonia (VAP) in a critically ill trauma patient.
  
  
  METHODS
  This report describes a 66-year-old critically ill trauma patient who developed VAP, which was caused by C indologenes. The patient was injured in a riding lawn mower accident that trapped him underwater in a pond. The patient required surgery for intra-abdominal injuries and was mechanically ventilated in the trauma intensive care unit. On hospital day 5, the patient developed signs and symptoms of VAP. A diagnosis of C indologenes VAP was confirmed based on a quantitative culture from a bronchoscopic bronchoalveolar lavage. The patient's infection was successfully treated with moxifloxacin for 2 days followed by cefepime for 7 days.
  
  
  CONCLUSIONS
  Formally known as Flavobacterium indologenes, C indologenes is a Gram-negative bacillus normally found in plants, soil, foodstuffs, and fresh and marine water sources. Recently, worldwide reports of C indologenes infections in humans have been increasing, though reports from the United States are still rare. Bacteremia and pneumonia are the most commonly reported infections, and most patients are immunocompromised. The current case differs from most previous reports because this patient was in the United States and did not have any traditional immunocompromised states (eg, transplant, cancer, HIV/AIDS, or corticosteroid use).
  
  
  CONCLUSIONS
  This case report demonstrates that C indologenes can cause VAP in a trauma ICU patient.
authors.affiliation: University of Tennessee Health Science Center, Memphis, TN, USA.
authors.forename: Megan R
authors.initials: MR
authors.lastname: Monteen
authors.forename: Supriya
authors.initials: S
authors.lastname: Ponnapula
authors.forename: G Christopher
authors.initials: GC
authors.lastname: Wood
authors.forename: Martin A
authors.initials: MA
authors.lastname: Croce
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Swanson
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Boucher
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Fabian
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use*; D000077723:Cefepime; D002511:Cephalosporins / Q000627:therapeutic use*; D045247:Chryseobacterium; D016638:Critical Illness; D045826:Flavobacteriaceae Infections / Q000000981:diagnostic imaging / Q000188:drug therapy*; D024841:Fluoroquinolones; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D000077266:Moxifloxacin; D053717:Pneumonia, Ventilator-Associated / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011804:Quinolines / Q000627:therapeutic use*; D011859:Radiography; D014947:Wounds and Injuries
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D002511:Cephalosporins; D024841:Fluoroquinolones; D011804:Quinolines; D000077723:Cefepime; D000077266:Moxifloxacin
keywords: Chryseobacterium indologenes; critical illness; trauma; ventilator-associated pneumonia